SIGA Technologies, Inc. Profile Avatar - Palmy Investing

SIGA Technologies, Inc.

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox dise…

Drug Manufacturers - Specialty & Generic
US, New York [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of SIGA's Analysis
CIK: 1010086 CUSIP: 826917106 ISIN: US8269171067 LEI: - UEI: -
Secondary Listings
SIGA has no secondary listings inside our databases.